Nadja Y West's most recent trade in Nucor Corp. was a trade of 1,554 Common Stock done . Disclosure was reported to the exchange on June 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nucor Corp. | Nadja Y. West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 1,554 | 9,948 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Nadja Y. West | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 1,551 | 0 | - | - | Restricted Stock Units | |
| Tenet Healthcare Corp. | Nadja Y. West | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 1,551 | 31,231 (0%) | 0% | - | Common Stock | |
| Tenet Healthcare Corp. | Nadja Y. West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 1,333 | 1,333 | - | - | Restricted Stock Units | |
| Tenet Healthcare Corp. | Nadja Y. West | Director | Sale or transfer of securities back to the company at price $ 161.33 per share. | 22 May 2025 | 573 | 30,658 (0%) | 0% | 161.3 | 92,442 | Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 1,997 | 32,068 | - | 0 | Class A Comnmon Stock | |
| Johnson & Johnson | Nadja Y. West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 1,316 | 6,572 | - | - | Deferred Share Units | |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 50.05 per share. | 17 Mar 2025 | 2,789 | 30,771 | - | 50.0 | 139,589 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 48.13 per share. | 17 Mar 2025 | 1,900 | 34,320 | - | 48.1 | 91,447 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 46.66 per share. | 17 Mar 2025 | 1,485 | 36,220 | - | 46.7 | 69,290 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 48.94 per share. | 17 Mar 2025 | 760 | 33,560 | - | 48.9 | 37,194 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 50.63 per share. | 17 Mar 2025 | 700 | 30,071 | - | 50.6 | 35,441 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 52.60 per share. | 04 Mar 2025 | 249 | 37,865 | - | 52.6 | 13,097 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 48.40 per share. | 04 Mar 2025 | 200 | 38,314 | - | 48.4 | 9,680 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 53.24 per share. | 04 Mar 2025 | 160 | 37,705 | - | 53.2 | 8,518 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 49.81 per share. | 04 Mar 2025 | 120 | 38,194 | - | 49.8 | 5,977 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y. West | Director | Sale of securities on an exchange or to another person at price $ 50.92 per share. | 04 Mar 2025 | 80 | 38,114 | - | 50.9 | 4,074 | Class A Common Stock |
| Tempus AI Inc. - Ordinary ... | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 38,514 | 38,514 | - | 0 | Class A Common Stock | |
| Nucor Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 1,006 | 8,394 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,551 | 1,551 | - | - | Restricted Stock Units | |
| Tenet Healthcare Corp. | Nadja Y West | Director | Sale of securities on an exchange or to another person at price $ 126.41 per share. | 09 May 2024 | 1,782 | 29,680 (0%) | 0% | 126.4 | 225,263 | Common Stock |
| Nucor Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 1,240 | 7,388 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 3,682 | 31,462 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 2,846 | 30,626 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 1,193 | 3,598 | - | - | Deferred Share Units | |
| Nucor Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 1,262 | 6,148 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 3,836 | 27,780 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,175 | 2,326 | - | - | Deferred Share Units | |
| Nucor Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 1,354 | 4,886 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 3,960 | 23,944 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Nadja Y West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 1,123 | 1,123 | - | - | Deferred Share Units |